About SynThera Biomedical

The startup develops specialty glass materials designed for bone tissue regeneration therapies, enabling healthcare professionals to utilize glass-based biomaterials in regenerative medicine. Their products provide affordable solutions that meet the stringent requirements of high-tech applications in the pharmaceutical and FMCG sectors.

```xml <problem> Current methods for bone and tissue regeneration often rely on materials that lack the necessary biocompatibility and bioactivity to effectively integrate with the body's natural healing processes. This can lead to slower healing times, increased risk of complications, and suboptimal regenerative outcomes. Furthermore, existing solutions may not always be affordable or readily customizable to meet specific clinical needs. </problem> <solution> Synthera develops and manufactures bioactive glass materials designed to enhance bone and tissue regeneration across a range of medical applications. Their products, including Porosyn and Therasenz, are formulated to mimic the composition of natural bone, promoting faster and more effective healing. Porosyn is a family of tissue repair and regeneration products optimized to release elements naturally present in human bone at rates that provide optimum osteostimulation. Therasenz, a 45S5 Bioglass, has demonstrated abilities to repair and regenerate tissues such as bone, dental enamel and skin. Synthera's bioactive glasses can be customized in terms of composition, porosity, and particle size to meet the specific requirements of diverse applications, from bone grafts and dental fillings to cosmetics and disinfection. </solution> <features> - Porosyn bioactive glass with a composition optimized for osteostimulation and bone regeneration - Therasenz 45S5 Bioglass for bone, dental enamel, and skin repair - Customizable particle sizes (from coarse to micron-fine) for powdered glass products - Capability to produce frit and cullet with tailored physical properties - Disinfectant glass formulations providing long-term disinfection via controlled ion release and pH modulation - Production using both crucible and day tank furnaces for highly customized glass compositions - Granules and blocks with customizable sizes for ease of handling in surgical procedures </features> <target_audience> Synthera's primary customers include clinicians performing dental, maxillofacial, and orthopedic surgeries, as well as companies in the pharmaceutical, medical device, cosmetics, FMCG, and water treatment industries. </target_audience> ```

What does SynThera Biomedical do?

Where is SynThera Biomedical located?

SynThera Biomedical is based in Pune, India.

When was SynThera Biomedical founded?

SynThera Biomedical was founded in 2015.

How much funding has SynThera Biomedical raised?

SynThera Biomedical has raised 330000.

Location

Pune, India

Founded

2015

Funding

330000

Employees

7 employees

Major Investors

Biotechnology Industry Research Assistance Council(BIRAC), 1Crowd

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

SynThera Biomedical

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

synthera.in 1K+

Crunchbase

Founded 2015 – Pune, India

Funding

Estimated Funding

$300K+

Major Investors

Biotechnology Industry Research Assistance Council(BIRAC), 1Crowd

Team (5+)

No team information available.

Company Description

Problem

Current methods for bone and tissue regeneration often rely on materials that lack the necessary biocompatibility and bioactivity to effectively integrate with the body's natural healing processes. This can lead to slower healing times, increased risk of complications, and suboptimal regenerative outcomes. Furthermore, existing solutions may not always be affordable or readily customizable to meet specific clinical needs.

Solution

Synthera develops and manufactures bioactive glass materials designed to enhance bone and tissue regeneration across a range of medical applications. Their products, including Porosyn and Therasenz, are formulated to mimic the composition of natural bone, promoting faster and more effective healing. Porosyn is a family of tissue repair and regeneration products optimized to release elements naturally present in human bone at rates that provide optimum osteostimulation. Therasenz, a 45S5 Bioglass, has demonstrated abilities to repair and regenerate tissues such as bone, dental enamel and skin. Synthera's bioactive glasses can be customized in terms of composition, porosity, and particle size to meet the specific requirements of diverse applications, from bone grafts and dental fillings to cosmetics and disinfection.

Features

Porosyn bioactive glass with a composition optimized for osteostimulation and bone regeneration

Therasenz 45S5 Bioglass for bone, dental enamel, and skin repair

Customizable particle sizes (from coarse to micron-fine) for powdered glass products

Capability to produce frit and cullet with tailored physical properties

Disinfectant glass formulations providing long-term disinfection via controlled ion release and pH modulation

Production using both crucible and day tank furnaces for highly customized glass compositions

Granules and blocks with customizable sizes for ease of handling in surgical procedures

Target Audience

Synthera's primary customers include clinicians performing dental, maxillofacial, and orthopedic surgeries, as well as companies in the pharmaceutical, medical device, cosmetics, FMCG, and water treatment industries.